Literature DB >> 20042339

Synthesis and disulfide bond connectivity-activity studies of a kalata B1-inspired cyclopeptide against dengue NS2B-NS3 protease.

Yaojun Gao1, Taian Cui, Yulin Lam.   

Abstract

Kalata B1 is a plant protein with remarkable thermal, chemical and enzymatic stability. Its potential applications could be centered on the possibility of using its cyclic structure and cystine knot motif as a scaffold for the design of stable pharmaceuticals. To discover potent dengue NS2B-NS3 protease inhibitors, we have prepared various kalata B1 analogues by varying the amino acid sequence. Mass spectrometric and biochemical investigations of these analogues revealed a cyclopeptide whose two fully oxidized forms are substrate-competitive inhibitors of the dengue viral NS2B-NS3 protease. Both oxidized forms showed potent inhibition with K(i) of 1.39+/-0.35 and 3.03+/-0.75 microM, respectively. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042339     DOI: 10.1016/j.bmc.2009.12.026

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

Review 1.  Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.

Authors:  Dipankar Chaudhuri; Teshome Aboye; Julio A Camarero
Journal:  Biochem J       Date:  2019-01-11       Impact factor: 3.857

Review 2.  Cyclotides: Overview and Biotechnological Applications.

Authors:  Andrew Gould; Julio A Camarero
Journal:  Chembiochem       Date:  2017-05-24       Impact factor: 3.164

Review 3.  Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications.

Authors:  Julio A Camarero
Journal:  Bioorg Med Chem Lett       Date:  2017-10-21       Impact factor: 2.823

Review 4.  The flavivirus protease as a target for drug discovery.

Authors:  Matthew Brecher; Jing Zhang; Hongmin Li
Journal:  Virol Sin       Date:  2013-11-14       Impact factor: 4.327

5.  Comparison of a Short Linear Antimicrobial Peptide with Its Disulfide-Cyclized and Cyclotide-Grafted Variants against Clinically Relevant Pathogens.

Authors:  Johannes Koehbach; Jurnorain Gani; Kai Hilpert; David J Craik
Journal:  Microorganisms       Date:  2021-06-08

6.  In vitro evaluation of novel inhibitors against the NS2B-NS3 protease of dengue fever virus type 4.

Authors:  Thi Thanh Hanh Nguyen; Sun Lee; Hsi-Kai Wang; Hsin-Yen Chen; Ying-Ta Wu; Simon C Lin; Do-Won Kim; Doman Kim
Journal:  Molecules       Date:  2013-12-13       Impact factor: 4.411

Review 7.  The Potential of the Cyclotide Scaffold for Drug Development.

Authors:  Julio A Camarero; Maria Jose Campbell
Journal:  Biomedicines       Date:  2019-04-19

Review 8.  Antiviral peptides as promising therapeutic drugs.

Authors:  Liana Costa Pereira Vilas Boas; Marcelo Lattarulo Campos; Rhayfa Lorrayne Araujo Berlanda; Natan de Carvalho Neves; Octávio Luiz Franco
Journal:  Cell Mol Life Sci       Date:  2019-05-17       Impact factor: 9.261

9.  Computer Aided Screening of Phytochemicals from Garcinia against the Dengue NS2B/NS3 Protease.

Authors:  Tahir Ul Qamar; Arooj Mumtaz; Usman Ali Ashfaq; Samia Azhar; Tabeer Fatima; Muhammad Hassan; Syed Sajid Hussain; Waheed Akram; Sobia Idrees
Journal:  Bioinformation       Date:  2014-03-19

10.  Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus.

Authors:  Hussin A Rothan; Hirbod Bahrani; Noorsaadah Abd Rahman; Rohana Yusof
Journal:  BMC Microbiol       Date:  2014-05-31       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.